We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PureTech Health said it will begin human trials on an experimental treatment for respiratory complications following recovery from COVID-19 infections. Read More
Novartis-subsidiary AveXis has entered into an agreement to manufacture a COVID-19 vaccine being developed by Massachusetts General Hospital and Massachusetts Eye and Ear. Read More
Top pharmaceutical executives pushed back yesterday against the World Health Organization’s plan for sharing patent rights and product data for COVID-19 countermeasures. Read More
GlaxoSmithKline (GSK) said it plans to manufacture 1 billion doses of its vaccine adjuvant next year to support multiple COVID-19 vaccine candidates. Read More
Roche has begun a phase 3 trial of its rheumatoid arthritis treatment Actemra (tocilizumab) with Gilead Sciences’ remdesivir for treatment of patients with severe COVID-19 pneumonia. Read More
The AIDS Law Project of Pennsylvania has filed a class action lawsuit in California against Gilead Sciences after the drug maker sent envelopes to users of its HIV prevention drugs with the return address “HIV Prevention Team” in red lettering. Read More
Maryland-based Novavax is expanding its manufacturing capacity for its COVID-19 vaccine candidate by acquiring a manufacturer in the Czech Republic as drugmakers rush to prepare for the global deployment of a successful vaccine. Read More
The FDA spelled out in a new guidance released yesterday how it will conduct formal meetings and deal with new drug applications during the COVID-19 pandemic. Read More